You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

SELENIOUS ACID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Selenious Acid, and when can generic versions of Selenious Acid launch?

Selenious Acid is a drug marketed by Am Regent and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has six patent family members in six countries.

The generic ingredient in SELENIOUS ACID is selenious acid. One supplier is listed for this compound. Additional details are available on the selenious acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Selenious Acid

A generic version of SELENIOUS ACID was approved as selenious acid by AM REGENT on April 30th, 2019.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SELENIOUS ACID?
  • What are the global sales for SELENIOUS ACID?
  • What is Average Wholesale Price for SELENIOUS ACID?
Summary for SELENIOUS ACID
International Patents:6
US Patents:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 55
Clinical Trials: 3
Patent Applications: 781
What excipients (inactive ingredients) are in SELENIOUS ACID?SELENIOUS ACID excipients list
DailyMed Link:SELENIOUS ACID at DailyMed
Drug patent expirations by year for SELENIOUS ACID
Recent Clinical Trials for SELENIOUS ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
American Regent, Inc.Phase 4
Shanghai Zhongshan HospitalN/A
Shanghai Changzheng HospitalN/A

See all SELENIOUS ACID clinical trials

Paragraph IV (Patent) Challenges for SELENIOUS ACID
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SELENIOUS ACID Intravenous Solution selenious acid 600 mcg/10 mL 209379 11 2024-06-11

US Patents and Regulatory Information for SELENIOUS ACID

SELENIOUS ACID is protected by one US patents and one FDA Regulatory Exclusivity.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-003 Aug 30, 2021 RX Yes Yes 11,998,565 ⤷  Subscribe Y ⤷  Subscribe
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-002 Jan 25, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-003 Aug 30, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-002 Jan 25, 2021 RX Yes Yes 11,998,565 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SELENIOUS ACID

See the table below for patents covering SELENIOUS ACID around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2022006426 ⤷  Subscribe
Canada 3186578 COMPOSITIONS D'OLIGO-ELEMENTS, LEURS PROCEDES DE FABRICATION ET D'UTILISATION (TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE) ⤷  Subscribe
China 116096423 微量元素组合物、制备方法及应用 (Microelement composition, preparation method and application) ⤷  Subscribe
Australia 2021300384 Trace element compositions, methods of making and use ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

SELENIOUS ACID Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Selenious Acid

Introduction to Selenious Acid

Selenious acid, a compound of selenium, has been gaining significant attention in various industries due to its versatile applications. This article delves into the market dynamics and financial trajectory of selenious acid, highlighting its growth drivers, market trends, and investment opportunities.

Market Growth Drivers

Several factors are driving the growth of the selenious acid market:

Increasing Demand in Pharmaceuticals

The pharmaceutical industry is a major driver, with a rising demand for selenium-enriched medications. Chronic diseases and the need for trace element supplementation have boosted the use of selenious acid in drug development. For instance, American Regent introduced the first FDA-approved Selenious Acid Injection in 2019, aligning with ASPEN recommendations for trace element supplementation[3][5].

Expanding Electronics Industry

The growing need for semiconductors and electronic devices has made selenious acid indispensable in manufacturing processes. Its use as a specialized oxidizing agent creates opportunities for market expansion[3].

Agricultural Advancements

The awareness of selenium's benefits in agriculture is leading to increased use of selenious acid in fertilizers, enhancing soil quality and crop productivity. This sector is expected to contribute significantly to the market's growth[1].

Market Trends

The selenious acid market is characterized by several key trends:

Innovative Product Development

Companies investing in research to develop high-purity selenious acid and selenium-based compounds are poised to capture significant market share. This innovation is crucial for meeting the stringent requirements of various industries[1].

Chemical Synthesis Applications

Selenious acid's applications in chemical synthesis are becoming more prominent, driven by its use as a specialized oxidizing agent. This has attracted significant investment from chemical industries[3].

Global Demand

The demand for selenious acid is rising in many parts of the world, driven by its diverse applications. Key players such as Central Drug House, Santa Cruz Biotechnology, and American Elements are pushing strong cash flow into the market[3].

Financial Trajectory

The financial outlook for the selenious acid market is robust:

Market Size and Projection

The global selenious acid market is projected to expand at a compound annual growth rate (CAGR) of around 5% over the next few years. Recent years have seen a swift and substantial rise, with forecasts indicating sustained significant expansion from 2023 to 2031[1][4].

Revenue Growth

The market is expected to generate substantial revenue, driven by increasing demand from pharmaceutical, electronics, and agricultural sectors. The presence of key players and their investment in research and development are further bolstering revenue growth[3][4].

Investment Opportunities

Investors can find promising opportunities in innovative product development, particularly in high-purity selenious acid and selenium-based compounds. Additionally, the expanding electronics and agricultural sectors offer lucrative investment avenues[1].

Challenges and Barriers

Despite the positive outlook, the selenious acid market faces several challenges:

Intense Competition

The market is highly competitive, with multiple players vying for market share. This competition can drive innovation but also poses challenges for new entrants[3].

Regulatory Compliance

Companies must comply with stringent regulatory requirements, especially in the pharmaceutical sector. For example, the FDA approval process for selenious acid injections is rigorous and time-consuming[5].

Regional Market Dynamics

The selenious acid market is not uniform across regions:

Key Markets

Countries like the USA, Germany, France, and China are expected to tap significant market shares in the coming era. These regions have strong industrial bases and high demand for selenious acid in various sectors[3].

Market Concentration

The market is moderately concentrated, with a mix of established and emerging players. This balance between concentration and fragmentation influences market dynamics and competition[3].

SWOT Analysis and Porter's Five Forces

A comprehensive SWOT analysis and Porter's Five Forces analysis provide deep insights into the market:

Strengths

  • Increasing demand from diverse industries
  • Innovative product development
  • Strong cash flow from key players

Weaknesses

  • Intense competition
  • Regulatory challenges
  • Dependence on raw material availability

Opportunities

  • Expanding electronics and agricultural sectors
  • Growing awareness of selenium's benefits
  • Emerging markets in developing countries

Threats

  • Economic downturns affecting demand
  • Substitute products
  • Environmental and health concerns related to selenium use[3][4].

Key Players and Their Strategies

Key players in the selenious acid market are adopting various strategies to maintain and expand their market share:

Product Diversification

Companies like American Elements and Omkar Speciality Chemicals are diversifying their product portfolios to include high-purity selenious acid and other selenium-based compounds[3].

Research and Development

Investments in R&D are critical for developing new applications and improving existing products. This strategy helps companies stay competitive and capture emerging market opportunities[1].

Illustrative Statistics and Examples

  • The global selenious acid market is projected to grow at a CAGR of around 5% over the next few years[1].
  • American Regent's introduction of the first FDA-approved Selenious Acid Injection in 2019 marked a significant milestone in the pharmaceutical sector[3][5].
  • Key players like Central Drug House and Santa Cruz Biotechnology are driving revenue growth through strong cash flow and strategic investments[3].

Quotes from Industry Experts

"The increasing demand for selenious acid in pharmaceuticals and electronics is a clear indicator of its growing importance across industries." - Praveen Kumar, Head & Director of Sales, AMA Research[3].

Highlight and Citation

"Selenious acid is used as a specialized oxidizing agent, creating opportunities for the market." - AMA Research Analyst[3].

Key Takeaways

  • The selenious acid market is experiencing significant growth driven by demand from pharmaceutical, electronics, and agricultural sectors.
  • Innovative product development and strong cash flow from key players are key drivers of market expansion.
  • The market faces challenges such as intense competition and regulatory compliance.
  • Regional dynamics vary, with key markets expected to drive significant growth.
  • SWOT analysis and Porter's Five Forces analysis highlight the market's strengths, weaknesses, opportunities, and threats.

FAQs

What are the primary growth drivers for the selenious acid market?

The primary growth drivers include increasing demand from the pharmaceutical industry, the expanding electronics industry, and agricultural advancements.

Which regions are expected to tap the highest market share in the coming era?

Countries like the USA, Germany, France, and China are expected to tap significant market shares due to their strong industrial bases and high demand for selenious acid.

What are the challenges faced by the selenious acid market?

The market faces intense competition, regulatory challenges, and dependence on raw material availability.

How is the market concentration of the selenious acid market?

The market is moderately concentrated, with a mix of established and emerging players.

What strategies are key players adopting to maintain and expand their market share?

Key players are adopting strategies such as product diversification, research and development, and strong cash flow investments to maintain and expand their market share.

Sources Cited

  1. Market Research Intellect - Unlocking Potential: The Expanding Horizons of the Selenic Acid Market.
  2. University of Iowa - FY 2016 Annual Economic Development Report.
  3. Advance Market Analytics - Global Selenous Acid Market - Latest Study Reveals New Growth Dynamics.
  4. Market Research Intellect - Global Selenious Acid Market Size, Scope And Forecast Report.
  5. FDA - NDA 209379 Selenious Acid Multi-Disciplinary Review and Evaluation.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.